Smoking Reduces Effectiveness of Multiple Medications Beyond Lung Harm

Pharmaceutical specialist Valentina Milovanova has indicated that the effectiveness of many drug classes may weaken or even be nullified if the patient is a smoker.

According to Milovanova, the affected medications include those for diabetes, cardiovascular diseases, antipsychotics, antidepressants, asthma and chronic obstructive pulmonary disease (COPD), blood clot prevention, and drugs acting on the central nervous system.

She explained, “After tobacco smoke is absorbed through the respiratory system, its components interact with medications, altering their absorption, distribution, metabolism, and excretion from the body. This results in changes in the drug concentration in the target organ and in the bloodstream, thereby modifying its effectiveness. Additionally, nicotine activates specific nicotine-sensitive receptors (n-AChR), stimulating adrenaline secretion into the blood, which increases vascular tension, raises blood pressure, accelerates heart rate, and elevates blood sugar levels, all of which impact drug efficacy. The influence is not limited to altering therapeutic effectiveness but may also increase side effects or toxicity.”

Milovanova noted that smoking reduces the effectiveness of diabetes medications such as insulin and metformin. The rise in blood sugar caused by increased adrenaline secretion can further weaken these drugs’ impact, potentially worsening the patient’s condition.

She added, “The second group includes cardiovascular disease treatments like beta blockers. Smoking diminishes the effectiveness of these drugs, potentially increasing the risk of hypertensive episodes. The third group comprises antipsychotics and antidepressants, where drug blood concentrations in smokers decrease by 30 to 50 percent, which may lead to schizophrenia relapse or severe depressive symptoms. The fourth group consists of asthma and COPD medications such as theophylline. While the drug’s effect lasts 6 to 12 hours in non-smokers, it drops to approximately 4 to 5 hours in smokers.”

The fifth group involves blood clot prevention drugs, where reduced effectiveness has been observed due to tobacco smoke components affecting drug metabolism and the coagulation system.

Milovanova also mentioned that certain drugs acting on the central nervous system are metabolized faster in smokers, leading to quicker breakdown and elimination from the body. This may cause the return of anxiety and insomnia symptoms, forcing physicians to adjust dosages for smokers. However, she emphasized that quitting smoking remains the easiest and safest option.